The Food and Drug Administration is expected to approve the first CRISPR gene-editing therapy.

Share:
More In Science
FDA Updates Ozempic Label
The Food and Drug Administration updated the labeling for Ozempic acknowledging reports of blocked intestines for those that use the medication.
Load More